7
Views
1
CrossRef citations to date
0
Altmetric
Literature Alerts

Literature Alerts

Pages 102-113 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • Self-quenching of fluorescence and triplet-triplet absorption of hypericin in liposomes of dipalmitoylphosphatidylcholine. BOUIRIG, H., ELOY, D. and JARDON, P., I. Chim. Phys. Phys-Chim. Biol., 1993, 90, (11-12), 2021–2038.
  • Miconazole, ketoconazole and liposomal preparations: A reversed-phase HPLC determi-nation. ALHAIQUE, F., ANCHISI, C., FADDA, A. M., MACCIONI, A. M., and TRAVAGLI, V., Acta Technol. Legis Med., 1993, 4, (3), 169–175.
  • Novel taxol formulations: preparation and characterization of taxol-containing liposomes. SHARMA, A., and STRAUBINGER, R. M., Pharm. Res., 1994, 11, (6), 889–896.
  • Direct gene transfer by liposomes. SINGHAL, A., and HUANG, L., Liposome Res., 1994,4, (1), 289–299.
  • Characterization of iopromide-carrying liposomes. SCHUHMANN, G. G., LEIKE, J., SACHSE, A., and KRAUSE, W., y. Liposome Res., 1994, 4, (1), 239–253.
  • Intrahepatic distribution of long-circulating liposomes containing polyethylene glycol-distearoylphosphatidylethanolamine. SCHERPHOF, G. L., MORSELT, H., and ALLEN, T. M., y. Liposome Res., 1994, 4, (1), 213–228.
  • Enhanced delivery and antitumor effect of doxorubicin encapsulated in long-circulating liposomes. MARUYAMA, K., UNEZAKI, S., YUDA, T., IsHIDA, O., TAKAHASHI, N., SUGINAKA, A., HUANG, L., and IWATSURU, My. Liposome Res., 1994, 4, (I), 143–165.
  • Human stratum corneum lipid-based liposomes. LASCH, J., SCHMITT, U., STERNBERG, B., and SCHUBERT, R.,.7. Liposomes Res., 1994, 4, (1), 93–106.
  • A polyol dilution method for mass production of liposomes. KIKUCHI, H., YAMAUCHI, H., and HIROTA, S., y. Liposome Res., 1994, 4, (I), 71–91.
  • Chemo-immunotherapy of liver metastases; The in vitro and in vivo effects of 5-fluorouracil combined with liposome-encapsulated muramyl dipeptide. DAEMEN, T., DONTE, B. H. J., REGTS, J., MORSELT, H., and SCHERPHOF, G. L., 1. Liposome Res., 1994,4, (1), 27–42.
  • Antibody-mediated targeting of long-circulating (Stealth) liposomes. ALLEN, T. M., AGRAWAL, A. K., AHMAD, I., HANSEN, C. B., and ZALIPSKY, S., y. Liposomes Res., 1994, 4, (1), 1–25.
  • Preliminary studies on erythromycin encapsulation in multilamellar liposomes. PANICO, A., PIGNATELLO, R., and MAZZONE, G., Hind. Antibiot. Bull., 1993, 35, (1-2), 395–397.
  • Study and characterization of biodegradable microspheres for parenteral administration, prepared by the spray-drying technique. FoREsTI, E., Boll. Chim. Farm., 1993, 132, (11), 481–487.
  • Anaesthetic efficacy of propanidid as a liposome dispersion. SUETTERLIN, R., Anaesthetist, 1994, 43, (1), 50–51.
  • Preparation of SUV-liposomes by high-pressure homogenization. PURMANN, T., MENTRUP, E., and KREUTER, J., Eur. y. Pharm. Biopharm., 1993, 39, (2), 45–52.
  • Inhibition of rat splenocyte proliferation with methylprednisolone: in vivo effect of liposomal formulation. MISHINA, E. V., and JusKo, W. J., Pharm. Res., 1994, 11, (6), 848–854.
  • Opsonic effect of globulins on phagocytosis of liposomes by bone marrow cells. BUMRAH, R., and PATEL, H. M., Btochem. Soc. Trans., 1994, 22, (2), 86S.
  • Albumin microspheres as a means of drug delivery to the lung: analysis of the effects of process variables on particle sizes using factorial design methodology. ZENG, X. M., MARTIN, G. P., and MARRiorr, C., Int. Y. Pharm., 1994, 107, (3), 205–210.
  • The effects of liposome surface charge and size on the intracellular delivery of clodronate and gallium in vitro. MOENKKOENEN, J., VALJAKKA, R., HAKASALO, M., and URTTI, A., /nt. Pharm., 1994, 107, (3), 189–197.
  • Freeze drying of liposomes with free and membrane-bound cryoprotectants-the background of protection and damaging processes. ENGEL, A., BENDAS, G., W I LHELM, F., MANNOVA, M., AUSBORN, M., and NUNN, P., Int. y. Pharm., 1994, 107, (2), 99–110.
  • Controlled release of proteins from poly(L-lactic acid) coated poly (isobutyl cyanoacrylate) microcapsules. PARK, T. G., ALONSO, M. J., and LANGER, R.,.7. Appl. Polym. Sci., 1994, 52, (12), 1797–1807.
  • Pharmacokinetics, biodistribution and therapeutic efficacy of doxorubicin encapsulated in Stealth liposomes (Doxil). WORKING, P. K., NEWMAN, M. S., HUANG, S. K., MAYHEW, E., VAAGE, J., and LASIC, D. D., y. Liposome Res., 1994, 4, 667–687.
  • The use of liposomes as carriers of lipophilic anthracycline antibiotics. PEREZ, S. R., Zou, Y., LING, Y. H., and PRIEBE, W., y. Liposome Res., 1994, 4, 555–573.
  • Doxorubicin encapsulated in long-circulating thermosensitive liposomes. MARUYAMA, K., and IWATSURU, M., y. Liposome Res., 1994, 4, 513–527.
  • The effect of liposomal phospholipids on the collagen-induced platelet aggregation. ZAKREVSKY, V. I., KUBATIEV, A. A., and GALAEv, Y. V., y. Liposome Res., 1994, 4, 315–324.
  • Biological action of liposomes on main pathogenetic mechanisms of inflammation. SHRAER, T. I., KREJNES, V. M., GOLUBCHIKOVA, N. A., USTJANTZEVA, I. M., MELJANTZEVA, L. P., and LAGUNOVA, N. T., J. Liposome Res., 1994, 4, (1), 281–288.
  • Liposome distribution under the conditions of transplantation immunity activation. SHRAER, T. I., SEMCHENKO, S. B., and GOLUBCHIKOVA, N. A., J. Liposome Res., 1994, 4, (1), 271–279.
  • The lung surfactant and immune system response to intratracheal administration of 'empty' liposomes. ROSENBERG, O. A., KIRILOV, Y. A., DANILOV, L. N., LOSHAKOVA, L. V., LEBEDEVA, E. S., SHULGA, A. E., and SES, T. P., y. Liposome Res., 1994, 4, (1), 203–212.
  • Clinical evaluation of liposome encapsulated doxorubicin and the modulation of multidrug resistance in cancer cells. RAHMAN, A., TREAT, J., THIERRY, A., HUSAIN, S. R., and DRITSCIIILO, A., y. Liposome Res., 1994, 4, (1), 167–192.
  • Interaction of pH-sensitive liposomes with blood components. Liu, D., and HUANG, L., J. Liposome Res., 1994, 4, (1), 121–141.
  • Stimulation of hematopoiesis by carboplatin liposomes. FICHTNER, I., RESZKA, R., BECKER, M., LEMM, M., RICHTER, J., BERGER, I., and RUDOLPH, M., J. Liposome Res., 1994, 4, (1), 43–69.
  • Isosorbide-5-mononitrate microcapsules: Formulation and evaluation of in vitro release profiles by application of factorial design. FARIVAR, M., KAS, H. S., ONER, L., and HINCAL, A. A., Hacettepe Univ. Eczacilik Fak. Derg., 1993, 13, (2), 25–37.
  • New crosslinked proteins for microsphere preparation. FORNI, F., SEGH IZZ I, R., BULGARELLI, E., CAMERONIL, R., and PIFFERI, G., Hind. Antibiot. Bull., 1993, 35, (1-2), 436–438.
  • Analysis of the preparative variables of albumin microspheres. FORNI, F., GoLooNi, C., and BERNABEI, M. T., Hind. Antibiot. Bull., 1993, 35, (1-2), 432–435.
  • Optimization of the composition of liposomes for delivering thymopentin. PANico, A., PIGNATELLO, R., CASTELLI, F., BINDONI, M., and MAZZONE, G., Hind. Antiobiot. Bull., 1993, 35, (1-2), 415–417.
  • Liposome-bound prostaglandin El often prevents cyclic flow variations in stenosed and endothelium-injured canine coronary arteries. WILLERSON, J. T., YAO, S. K., MCNATT, J., Cui, K., ANDERSON, H. V., SWENSEN, C., OSTRO, M., and BUJA, L. M., Circulation, 1994,89, (4), 1786–1791.
  • The role of polyisobutylene and the effect of its concentration in the microencapsulation of isoniazid. BARIK, B. Et., GUPTA, B. K., and PAL, M., Indian Drugs, 1994, 31, (3), 104–108.
  • Temperature-sensitive liposomes: liposomes bearing poly(N-isopropylacrylamide). KONO, K., HAYASHI, H., and TAKAGI SHI, T., J. Controlled Release, 1994, 30, (1), 69–75.
  • Plasma factor triggering alternative complement pathway activation by liposomes. FUNATO, K., YAmAsH1TA, C., KAMADA, J., Tom INAGA, S., and KIWADA, H., Pharm. Res., 1994, 11, (3), 372–376.
  • Liposomes as a mucosal adjuvant system: An intranasal liposomal influenza subunit vaccine and the role of IgA in nasal anti-influenza immunity. WILSCHUT, J., DE HAAN, A., GEERLIGS, H. J., HUCHSHORN, J. P., VAN SCIIARRENBURG, G. J. M., PALACHE, A. M., RENEGAR, K. B., and SMALL, P. A. JR., y. Liposome Res., 1994, 4, (1), 301–314.
  • Target-sensitive liposomes. HUANG, L., y. Liposome Res., 4, 1994, 397–412.
  • pH-sensitive liposomes. CHu, C. J., and SZOKA, C. JR., y. Liposome Res., 1994, 361–395.
  • Pulmonary delivery of liposomal drugs. SCHREIER, H., y. Liposome Res., 1994, 4, (I), 229–238.
  • Chemo-occlusion for the treatment of liver cancer. A new technique using degradable starch microspheres. TAGUCHI, T., Clin. Pharmacokinet., 1994, 26, (4), 275–291.
  • Influence of lecithins on the skin absorption of vitamins A and E from liposomes. SzuLc, J., WOYCZIKOWSKI, B., SZCZEPANSKA, M., CAL, K., WOLNIAK, L., SOSADA, M., PASKER, B., and WAsowiez, K., Pharmazie, 1994, 49, (4), 295.
  • Laminar forced convection heat transfer in microcapsulated phase change material suspensions. GOEL, M., Roy, S. K., and SENGUPTA, S., Int. J. Heat Mass. Transfer, 1994, 37, (4), 593–604.
  • Treatment of textile materials with microencapsulated substances (repellents and fragrances). LIPATOVA, I. M., ZHELEZNOV, K. N., MAKAROVA L. I., and TIRKIYA, G. R., Tekstil Khimiya, 1992, (2), 92–96.
  • Dielectric study of hollow microsphere composites. ANSERMET, J. P., and BAERISWYL, E. J. Mater. Sci., 1994, 29, (11), 2841–2846.
  • Morphology control using core-shell type polymer microsphere. SAITO, R., KOTSUBO, H., and IsHizu, K., Polymer, 1994, 35, (11), 2296–2301.
  • Phase-separated polymerization (II). Synthesis of functional microspheres with diethyl-aminoethyl group. WANG, S., ZHANG, X., WANG, Z., YUAN, Rand ZHAO, X., Gaofenzi Xuebao, 1992, (4), 484–487.
  • The study of lipid aggregates in aqueous solution: formation and properties of liposomes with an encapsulated metallochromic dye. JAKusowsK 1, H. V., PENAS, M., and SAUNDERS, K., 1. Chem. Educ., 1994, 71, (4), 347–349.
  • Induction of immunity against experimental tuberculosis with mycobacterial manno-phosphoinositides encapsulated in liposomes containing lipid A. SINGH, A. P., and KHULLER, G. K., FEMS Immunol. Med. Microbiol., 1994, 8, (2), 119–126.
  • Adjuvant effect of liposomes and adamantylamide dipeptide on antigenicity of entrapped synthetic peptide derived from HIV-1 transmembrane region glycoprotein gp41, TURANEK, J., TOMAN, M., NOVAK, J., KRCHNAK, V., and HORAVOVA, P., Immunol. Lett., 1994,39, (2), 157–161.
  • Liposome-encapsulated muramyl tripeptide up-regulates monocyte chemotactic and activat-ing factor gene expression in human monocytes at the transcriptional and post-transcriptional levels. ASANO, T., MATSUSHIMA, K., and KLEINERMAN, E. S., Cancer Immunol. Immunother., 1994, 38, (1), 16–22.
  • Taste receptor proteins directly extracted by liposome from intact epithelium of bullfrog tongue. NAKAMURA, M., TSUJII, K., KATSURAGI, Y., KURIHARA, K., and SUNAMOTO, J., Biochem. Biophys. Res. Commun., 1994, 201, (1), 415–422.
  • Effects of cholesterol and azelaic acid in lecithin liposomes exposed to ELF fields: a thermodynamic and structural study. DUBIN', B., GUIDI, G. M., MONTECCHIA, F., PERGOLINI, M., PONZI, B. M. G., and VETRANO, F., Nuovo Cimento Soc. Ital. Fis., D, 1994, 16D, (2), 207–211.
  • Interaction between zinc(II)-phthalocyanine-containing Liposomes and human low density lipoprotein. VERSLUIS, A. J., RENSEN, P. C. N., KUIPERS, M. E., LOVE, W. G., and TAYLOR, P. W., J. Photochem. Photobiol., B, 1994, 23, (2-3), 141–148.
  • Calcium ions reverse a latency period induced by bovine serum albumin in the time course of phospholipase A2 action on 1,2-dipalmitoyl-s n-glycero-3-phosphocholine liposomes. PACHECO, F., ME)IA, R., and FERNANDEZ, M. S., Biochem. Cell. Biol., 1993, 71, (9-10), 462–466.
  • A sustained cytoplasmic transgene expression system delivered by cationic liposomes. GAO, X., JAFFURS, D., ROBBINS, P. D., and HUANG, L., Biochem. Biophys. Res. Commun., 1994, 200, (3), 1201–1206.
  • Effect of immunomodulators on specific tumor immunity induced by liposome-encapsulated tumor-associated antigens. BERGERS, J. J., DEN, O. W., DULLENS, H. F. J., DE GROOT, J. W., STEERENBERG, P. A., FILios, P. M. G., and CROMMELIN, D. J. A., mt. y. Cancer, 1994, 56, (5), 721–726.
  • Liposomal mitoxantrone for the local treatment of peritoneal carcinomatosis induced by colon cancer in mice. GENNE, P., OLSSON, N. O., GUTIERREZ, G., DUCHAMP, O., and CHAUFFERT, B., Anti-Cancer Drug Des., 1994, 9, (2), 73–84.
  • Degradable starch microspheres in cytostatic treatment of a liver carcinoma; experimental studies in rats with 5-fluorouracil, tauromustine, carmustine, doxorubicin, and R SU–1069.
  • Roos, G., CHRISTENSSON, P. T., EL HAG, I. A., JAKOBSSON, B., TEDER, H., and STENRAM, U., Anticancer Res., 1993, 13, (3), 635–641.
  • Fusion of influenza to liposomes is not inhibited by aliphatic primary alcohols. LEMAY, C. T. Y., CECCARELLI, D. F. J., and EPAND, R. M., Biosci. Rep., 1994, 14, (1), 33–42.
  • Liposomes: technological, biological and pharmacological aspects. DELATTRE, J., COUVREUR, P., PUISIEUX, F., PHILIPPOT, J. R., and SCHUBER, F., Editions INSERM, Paris, France, 1993, 266 pp.
  • Preparation of surface-modified polystyrene microspheres by an azo-initiator having analogous structure to the head group of phosphatidylcholine. SUGIYAMA, K., OHGA, K., and KIKUKAWA, K., Macromol. Chem. Phys., 1994, 195, (4), 1341–1352.
  • Formulation and in vitro performance of liposome powder aerosols. SCHREIER, H., MOBLEY, W. C., CONCESSIO, N., HICKEY, A. J., and NIVEN, R. W STP Pharma. Sci ., 1994, 4, (1), 38–44.
  • Preparation and characterization of bupivacaine-loaded polylactide and poly(lactide-glycolide) microspheres. LE CORRE, P., LE GUEVELLO, P., GAJAN, V., CHEVANNE, F., and LE VERGE, R., Int. J. Pharm., 1994, 107, (1), 41–49.
  • Preparation and evaluation of methotrexate-loaded biodegradable polyanhydride micro-spheres. BHAGAT, H. R., HOLLENBECK, R. G., PANDE, P. G., BOGDANSKY, S., FAIT, C. D., and ROCK, M., Drug Der. Ind. Pharm., 1994, 20, (10), 1725–1737.
  • Sustained-release dosage form of phenylpropanolamine hydrochloride. Part I: micro-encapsulation and in vitro release kinetics. SEVGI, F., OZYAZICI, M,., and GUNERI, T., y. Microencapsulation, 1994, 11, (3), 327–334.
  • Sustained-release dosage form of phenylpropanolamine hydrochloride. Part II: Formulation and in vitro release kinetics from tableted microcapsules. SEVGI, F., OZYAZICI, M., and GUNERI, T., J. Microencapsulation, 1994, 11, (3), 335–344.
  • A method for preparation of unilamellar liposomes for extemporaneous clinical use. LIAUTARD, J. P., and PHILIPPOT, J. R., Liposomes, Ed. INSERM, Paris, 1993, 63–68.
  • Pharmaceutical development of CGP 55847 a liposomal Zn-phthalocyanine formulation using a controlled organic solvent dilution method. I SELE, U., VAN HOOGEVEST, P., LEUENBERGER, H., CAPRARO, H. G., and SCHIEWECK, K., Proc. SPIE-Int. SOC. Opt. Eng., 1994, 2078, (Photodynamic Therapy of Cancer), 397–403.
  • High lung uptake of 99mTc-multilamellar liposomes after intravenous administration in rats and rabbits. NINIO, S., YAMBOLIEV, I., and KOVACHEVA, S., Pharmazie, 1994, 49, (5), 353–356.
  • Preparation and stability of liposome encapsulated doxorubicin and mitoxantrone and their internalization by murine peritoneal macrophages. LILLEY, J. C., PATTERSON, L. H., and TAYLOR, M. J., Int. y. Pharm., 1994, 107, (2), 149–157.
  • Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors. BOMAN, N. L., MASIN, D., MAYER, L. D., CuLT,Is, P. R., and BALLY, M. B., Cancer Res., 1994, 54, (11), 2830–2833.
  • Sustained release of phenytoin following the oral administration of phenytoin sodium/ethyl cellulose microcapsules in human subjects and rabbits. KARAKASA, I., YAGI, N., SHIBATA, M., KENMOTSU, H., SEKIKAWA, H., and TAKADA, M., Biol. Pharm. Bull., 1994, 17, (3), 432–436.
  • Characterization and kinetics of MHC class I-restricted presentation of a soluble antigen delivered by liposomes. ZHOU, F., WATKINS, S. C., and HUANG, L., Immunobiology (Stuttgart), 1994, 190, (1-2), 35–52.
  • Surface modified polymer microspheres obtained by the emulsion copolymerization of 2-methacryloyloxyethyl phosphorylcholine with various vinyl monomers. SUGIYAMA, K., and AOKI, H., Polym. J. (Tokyo), 1994, 26, (5), 561–569.
  • Effect of soybean-derived sterol, and its glucoside mixtures on the stability of dipalmitoyl-phosphatidylcholine and dipalmitoylphosphatidylcholine/cholesterol liposomes. MURAMATSU, K., MAITANI, Y., MACHIDA, Y., and NAGAI, T., ha. y. Pharm., 1994, 107, (1), 1–8.
  • Internalization of cell surface molecules: implications for liposome targeting. MACHY, P., and LESREMAN, L., Liposomes, Ed. INSERM, Paris, France, 1993, 137–147.
  • Decreased toxicity of liposomal amphotericin B due to association of amphotericin B with high-density lipoproteins: role of lipid transfer protein. WASAN, K. M., LOPEZ, B. G., MoRTEN, R. E., and ROSENBLUM, M. G., y. Pharm. Sci., 1994, 83, (7), 1006–1010.
  • Stabilization of topotecan in low pH liposomes composed of distearoylphosphatidylcholine. BURKE, T. G., and GAO, X., y . Pharm. Sci., 1994, 83, (7), 967–969.
  • Gelatin microspheres as a new approach for the controlled delivery of synthetic oligo-nucleotides and PCR-generated DNA fragments. CORTESI, R., ESPOSITO, E., MENEGATTI, E., GAMBARI, R., and NASTRUZZI, C., Int. J. Pharm., 1994, 105, (2), 181–186.
  • The morphology of progesterone-loaded polystyrene microspheres. COURTEILLE, F., BENOIT, J. P., and THIES, C., y. Controlled Release, 1994, 30, (1), 17–26.
  • Daunomycin-human albumin microspheres: Preparation, characterization and use in experimental cancer therapy. ZHONG, W., WANG, R., and GUAN, S., junshi Yixue Kexueyuan Yuankan, 18, (1), 33–35.
  • Liposomal entrapment of suramin. CHANG, H. C., and FLANAGAN, D. R., y. Pharm. Sci., 1994, 83, (7), 1043–1046.
  • Liposomes in host defense mechanism: a key role for macrophages. VAN RooiTEN, N., J. Liposome Res., 1994, 4, (1), 193–201.
  • Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. SCHREIER, H., and BOUWSTRA, J., J. Controlled Release, 1994, 30, (1), 1–15.
  • Manufacture of joints with increased corrosion resistance using rivets with a microencapsu-lated coating. BRUK, O. A., Nauch-Tekhn Dostizh, Vseros Nii Mezhotrasl Inf., 1992, (6), 10–12.
  • Isolation and characterization of addition products of alpha-tocopherol with peroxyl radicals of dilinoleoylphosphatidylcholine in liposomes. YAMAUCHI, R., YAGI, Y., and KATO, K., Biochim. Biophys. Acta., 1994, 1212, (1), 43–49.
  • Adsorption of monoclonal IgG on polystyrene microspheres. GALISTEO, G. F., MARTIN, R. A., and HIDALGO, A. R., Colloid. Polym. Sci., 1994, 272, (3), 352–358.
  • The effect of liposome (apoA-IV: DMPC) on LDL receptor expression. Hu, Y. M., Wu, G., and XUE, H., Shengwu Huaxue Yu Shengwu Wuli Xuebao, 1993, 25, (4), 361–365.
  • Cholesterol content in liposomes regulates their interaction with blood serum lipoproteins. ZAKHAROVA, T. S., IvANov, A. S., ECHKALOV, A. P., BEREZOV, A. T., KHALILOV, E. M., and ARCHAKOV, A. I., Biokhimiya (Moscow), 1994, 59, (5), 712–719.
  • Acoustical investigation of the liposome-saccharide interaction. BABINCOVA, M., and HIANIK, T., Acta Biochim. Pol., 1993, 40, (4), 483–486.
  • 90-Y glass therapy microsphere for the treatment of malignant tumors. Yu, H., JIN, X., WANG, Y., YANG, Z., ZHANG, P., and J1A, G., He Huaxue Yu Fangshe Huaxue, 1993, 15, (3), 156–160.
  • Immobilization of enzymes by multilayer microcapsules. POMMERSHEIM, R., SCEIREZENMEIR, J., and VOGT, W., Macromol. Chem. Phys., 1994, 195, (5), 1557–1567.
  • The cysteine-rich region of Raf-1 kinase contains zinc, translocates to liposomes, and is adjacent to a segment that binds GTP-Ras. GliosH, S., XIE, W. Q., QUEST, A. F. G., MABROUK, G. M., STRUM, J. C., and BELL, R. wf y. Biol. Chem., 1994, 269, (13), 10000–10007.
  • Lens major intrinsic protein (MIP) promotes adhesion when reconstituted into large unilamellar liposomes. MICHEA, L. F., DE LA FUENTE, M., and LAGOS, N., Biochemistry, 1994, 33, (24), 7663–7669.
  • Effect of high pressure on induced lipid peroxidation in liposomal membranes. VDOVIN, A. V., TYURIN, K., MIN, A. Y., and VANDYSHEV, D. B., Biokhimiya (Moscow), 1994, 59, (5), 720–725.
  • Polymerized monolayers, bilayers and liposomes as biological membrane models. ZHou, Q., HE, Y., and LIN, Y Daxue Huaxue, 1994, 9, (1), 25–30.
  • Stimulation of trigeminal motoneurons by in vivo implantation of glutamate-impregnated microspheres. BYRD, K., DomB, A. J., SOKOLOFF, A. J., and HAMILTON, B., Polym. Adv. Technol., 1992, 3, (6), 337–344.
  • Tissue distribution and therapeutic effect of intravenous free or encapsulated liposomal doxorubicin on human prostate carcinoma xenografts. VAAGE, J., BARBERA, G. E., ABRA, R., HUANG, A., and WORKING, P., Cancer (Philadelphia), 1994, 73, (5), 1478–1489.
  • Therapy of human ovarian carcinoma xenografts using doxorubicin encapsulated in sterically stabilized liposomes. VAAGE, J., DONOVAN, D., MAYHEW, E., ABRA, R., and HUANG, A., Cancer (Philadelphia), 1993, 72, (12), 3671–3675.
  • Cellular accumulation and DNA damage induced by liposomal cis-bis-neodecanoate-trans-R, R-1,2-diaminocyclohexane platinum(II) in LoVo and LoVo/PDD cells. HAN, I., THUAN, N., YANG, L. Y., KHOKHAR, A. R., and PEREZ, S. R., Anti-Cancer Drugs, 1994, 5, (1), 64–68.
  • Potentiation of ricin cytotoxicity by liposomal monensin under in vitro and in vivo conditions. MADAN, S, VASANDANI, V. M., and GHOSH, P. C., Indian J. Biochem. Biophys., 1993, 30, (6), 405–410.
  • Microcapsules. Application to recording materials. MARUYAMA, M., Porima Daijesuto, 1994, 46, (4), 61–69.
  • Amphotericin B liposomes sterility test procedure. Lou, X., ZHAO, X., and Zxu, Q., Zhongguo Yaoke Daxue Xuebao, 1994, 25, (1), 36–38.
  • Biodegradable microspheres as depot system for parenteral delivery of peptide drugs. MEHTA, R. C., JEYANTHI, R., CALIS, S., THANOO, B. C., BURTON, K. W., and DELucA, P. P., y. Controlled Release, 1994, 29, (3), 375–384.
  • Effect of loading method on NSAIDs release from ethylene glycol dimethacrylate crosslinked poly(2-hydroxyethyl methacrylate) microspheres. ORIENT, I., GIANASI, E., ZECCHI, V., and MONOGIORGI, R., Farmaco, 1993, 48, (11), 1577–1595.
  • Casein microspheres: preparation and evaluation as a carrier for controlled drug delivery. JAYAKRISHNAN, A., KNEPP, W. A., and GOLDBERG, E. P., Int. J. Pharm., 1994, 106, (3), 221–228.
  • Preparation and evaluation of sustained-release microspheres of terbutaline sulfate. KIM, C. K., Kim, M. J., and OH, K. H., Int. J. Pharm., 1994, 106, (3), 213–219.
  • Preparation and preclinical evaluation of bioresorbable hydroxyethyl starch microspheres for transient arterial embolization. FOURNIER, C., HAMON, M. HAMON, M., WANNEBROUCQ, J., PETIPREZ, S., PRUVO, J. P., and HECQUET, B., Int. y., Pharm., 1994, 106, (1), 41–49.
  • Encapsulating mitomycin C in albumin microspheres markedly alters pharmacokinetics, drug quinone reduction in tumor tissue and antitumor activity. Implications for the drugs' in vivo mechanism of action. CummINGS, J., ALLAN, L., and SMYTH, J. F., Blochem. Pharmacol., 1994, 47, (8), 1345–1356.
  • Autoradiographic study of distribution of tritiated 5-FU microspheres in lung after injection into mice. SUN, J., CHEN, X., ZHANG, Z., and SHI, T., Yunshi Yixue Kexueyuan Yuankan, 1994, 18, (I), 30–32.
  • Design of new building blocks in resorbable polymers. Application in drug delivery microspheres. ALBEBTSSON, A. C., LoEFGBEN, A., STURESSON, C., and SJOELING, M., ACS Symp. Ser., 1994, 545 (Polymeric Drugs and Drug Administration), 172–180.
  • Differential disposition of soluble and liposome-formulated human recombinant interleukin-7: effects on blood lymphocyte population in guinea pigs. Bui, T., FALTYNEK, C., and Ho, R. J. Y Pharm. Res., 1994, 11, (5), 633–641.
  • Construction of drug delivery system by liposome for control of its movement from bodies to cells. HARASHIMA, H., Farumashia, 1994, 30, (5), 496–501.
  • Liposomes for gene transfer in mammalian cells. LEGENDRE, J. Y., and SZOKA, F., Liposomes, Ed. INSERM, Paris, 1993„ 245–260.
  • Liposomes and vaccines. PERRIN, P., Liposomes, Ed. INSERM, Paris, 1993, 225–243.
  • Liposomes in human clinical study: therapeutic results. COUVREUR, P., Liposomes, Ed INSERM, Paris, 1993, 215–224.
  • Pharmacokinetics and therapeutic potentials of liposomes. DEVISSAGUET, J. P., and PuisIEUX, F., Liposomes, Ed. INSERM, Paris, 1993, 179–213.
  • Liposomes and endothelial barriers. DELATTRE, J., Liposomes, Ed. INSERM, Paris, 1993, 167–178.
  • Fusogenic liposomes. PHILIPPOT, J. R., MII,HAUD, P. G., COMPAGNON, B., and BIENVENUE, A., Liposomes, Ed. INSERM, Paris, 1993, 149–166.
  • Reactions and techniques for the binding of ligands to liposomes. SCHUBER, F., and FRISCH, B., Liposomes, Ed. INSERM, Paris, 1993, 113–136.
  • Techniques for liposome labeling. OLLIVON, M., and PATERNOSTRE, M., Liposomes, Ed. INSERM, Paris, 1993, 87–112.
  • Methods for liposome characterization. VIDAL, M., Liposomes, Ed. INSERM, Paris, 1993, 69–86.
  • Methods for the preparation of liposomes. FATTAL, E., COUVREUR, P., and PUISIEUX, F., Liposomes, Ed. INSERM, Paris, 1993, 43–62.
  • Liposomes as penetration promoters and localizers of topically applied drugs. MEZEI, M., Drugs Pharm. Sci., 1994, 62, 171–198.
  • Liposomes: the long-term stability and the topical effect to the skin. ARAKANE, K., HAVASHI, K., NAITO, N., IWANAGA, K., YAMASHITA, S., and OKU, N., J. sccy, 1993, 27, (3), 216–262.
  • The properties of lecithin and lecithin-liposome containing emulsions, emulsified with crosslinked acrylic acid-alkyl acrylate crosspolymer. Up, K., TAKAHASHI, K., and HEMKER, W., .7. sccy, 1993, 27, (3), 206–215.
  • Preparation of microspheric alumina support by spray drying process. Zulu, H., Shiyou Huagong, 1993, 22, (6), 401–403.
  • Effect of surfactants on the particle sizes of Red #170 polyurea microcapsules. Kuo, Y. M., Wu, C. T., Wu, W. H., and CHAO, D. Y., I. Appl. Polym. Sci., 1994, 52, (8), 1165–1173.
  • Liposome-complement interactions in rat serum: implications for liposome survival studies. DEVINE, D. V., WONG, K., SERRANO, K., CHONN, A., and Cui,Lis, P. R., Biochim. Biophys. Acta, 1994, 1191, (1), 43–51.
  • The 114 -ATPase from reticulocyte endosomes reconstituted into liposomes acts as an iron transporter. Li, C. Y., WATKINS, J. A., and GLASS, J., J. Biol. Chem., 1994, 269, (14), 10242–10246.
  • Preparation and sugar binding property of microspheres having surface-anchored phenyl-bornic acid groups.TsuKAGositi, K., KAWASAKI, R., MAEDA, M., and TAKAGI, M., Chem. Lett., 1994, (4), 681–684.
  • Preparation of lucifer yellow fluorescent liposomes: a method for cells' membrane labeling. MENNA, C., CALONGHI, N., MASOTTI. L., and NEYROZ, P.7. Fluoresc., 1993, 3, (1), 33–43.
  • Fast-protein liquid chromatography system as a tool for liposome preparation by the extrusion procedure. TURANEK, J., Anal. Biochem., 1994, 218, (2), 352–357.
  • A polycation causes migration of negatively charged phospholipids from the inner to outer leaflet of the liposomal membrane. YAROSLAVOV, A. A., KuLicov, V. E., POLINSKY, A. S., BAIBAKOV, B. A., and KABANOV, V. A., FEBS Lett., 1994, 340, (1-2), 121–123.
  • Trehalose inhibits ethanol effects on intact yeast cells and liposomes. MANSURE, J. J. C., PANEK, A. D., CROWE, L. M., and CROWE, J. H., Biochim. Biophys. Acta, 1994, 1191, (2), 309–316.
  • Interaction of bombolitin III with phospholipid monolayers, and liposomes and effect on the activity of phospholipase A2. SIGNOR, G., MAMMI, S., PEGGION, E., RINGSDORF, H., and WAGENKNECHT, A., Biochemistry, 1994, 33, (21), 6659–6670.
  • Effects of naftidrofuryl oxalate on microsphere embolism-induced decrease in regional blood flow of rat brain. MIYAKE, K., TAKAGI, N., and TAKEO, S., Br. y. Pharmacol., 1994, 112, (1), 226–230.
  • Antiproliferative activity of thermosensitive liposome-encapsulated doxorubicin combined with 43°C hyperthermia in sensitive and multidrug-resistant MCF-7 cells. MERLIN, J. L., MARCHAI„ S., RAMACCI, C., NOTTER, D., and VIGNERON, C., Ear. y. Cancer, Part A, 1993, 29A, (16), 2264–2268.
  • Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-martnitol and serum galactomannan as markers of infection. FRANCIS, P., LEE, J. W., HOFFMAN, A., PETER, J., FRANCESCONI, A., BACHER, J., SHELHAMER, J., Pizzo, P. A., and WALSH, T. J., J. Infect. Dis., 1994, 169, (2), 356–368.
  • Phagocytosis by cultured mouse peritoneal macrophages of microspheres coated with perfluoroalkylated telomeric surfactants derived from tris(hydroxymethyl)-aminomethane. PRI VITERA, N., NAON, R., and RIESS, J. G., Int. y. Pharm.,1994, 104, (1), 41–48.
  • Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa. OMRI, A., BEAULAC, C., BOUHAJIB, M., MONTPLAISIR, S., SHARKAWI, M., and LAGACE, J., Antimicrob. Agents Chemother., 1994, 38, (5), 1090–1095.
  • RP-HPLC study on the distribution of praziquantel in mouse and it's liposome. BAD, Q., and GAO, S., Fenxi Ceshi Xuebao, 1993, 12, (1), 48–50.
  • Production of Synroc ceramics from titanate gel microspheres. SIZGEK, E., BARTLETT, J. R., WOOLFREY, J. L., and VANCE, E. R., Mater. Res. Soc. Symp. Proc., 1994, 333, 305–312.
  • Neoglycoprotein-conjugated liposomes as macrophage specific drug carrier in the therapy of leishmaniasis. KOLE, L., SARKAR, K., MAHATO, S. B., and DAs, P. K., Biochem. Biophys. Res. Commun., 1994, 200, (1), 351–358.
  • Potential usage of thermosensitive liposomes for macromolecule delivery. OKu, N., NARUSE, R., Doi, K., and OKADA, S., Biochim. Biophys. Acta, 1994, 1191, (2), 389–391.
  • Increase of liposome stability by incorporation of bovine serum albumin. LAW, S. L., Lo, W. Y., and UN, M., Drug Dev. Ind. Pharm., 1994, 20, (8), 1411–1423.
  • Preparation, characterization and in-vitro release kinetics of salbutamol sulfate loaded albumin microspheres. KARUNAKAR, S., and SINGH, J., Drug Dev. Ind. Pharm., 1994, 20, (8), 1377–1399.
  • Kinetic modeling of liposome degradation in serum: effect of size and concentration of liposomes in vitro. HARASHIMA, H., OCHI, Y., and K1WADA, H., Biopharm. Drug Dispos., 1994, 15, (3), 217–225.
  • Fat-soluble vitamins in liposomes: studies on incorporation efficiency and bile salt induced vesicle disintegration. KIRILENKO, V. N., and GREGORIADIS, G., J. Drug Targeting, 1993, 1, (4), 361–368.
  • Distribution within the organs of a reticuloendothelial system of liposomes containing lipid A. PARK, Y. S., and HUANG, L., J. Drug Targeting, 1993, 1, (4), 325–330.
  • Activity of liposomal amphotericin B (AmBisome) against Leishmania infantum and tissue distribution in mice. GRADON1, L., DAVIDSON, R. N., ORSINI, S., BETTO, P., and GIAMBENEDETTI, M., y . Drug Targeting, 1993, 1, (4), 311–316.
  • Liposomal (MLV) polymyxin B: physicochemical characterization and effect of surface charge on drug association. LAWRENCE, S. M., ALPAR, H. O., MCALLISTER, S. M., and BROWN, M. R. W., J. Drug Targeting, 1993, 1, (4), 303–310.
  • Application of lipid microspheres to prepare a thromboxane A2 receptor antagonist aerosol for inhalation. TAKENAGA, M., NAKAGAWA, T., IGARASHI, R., and MIZUSHIMA, Y., y. Drug Targeting, 1993, 1, (4), 293–301.
  • Enhanced tumor targeting of doxorubicin by ganglioside GM1-bearing long-circulating liposomes. UNEZAKI, S., MARUYAMA, K., ISHIDA, O., TAKAHASHI, N., and IWATSURU, M., J. Drug Targeting, 1993, 1, (4), 287–292.
  • Elimination of a subpopulation of Kupffer cells by liposome-encapsulated dichloromethylene diphosphonate suppresses the endotoxin-induced activation of hepatic macrophages. BAUTISTA, A. P., SKREPNIK, N., NIESMAN, M. R., and BAGBY, G. J., Cells Hepatic Sinusoid., 1993, 4, 48–50.
  • Controlled release of thyrotropin releasing hormone from microspheres: evaluation of release profiles and pharmacokinetics after subcutaneous administration. HEYA, T., MI KURA, Y., NAGAI, A., MIURA, Y., FUTO, T., TOMIDA, Y., SHIMIZU, H., and TOGUCHI, H., 7. Pharm. Sci., 1994, 83, (6), 798–801.
  • Topical dosage form of liposomal tetracaine: effect of additives on the in vitro release and in vivo efficacy. FOLDVARI, M., JARVIS, B., and OGUEJI0FOR, C. J. N.,. Controlled Release, 1993, 27, (3), 193–205.
  • Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. ALONSO, M. J., GUPTA, R. K., MIN, C., SIBER, G. R., and LANCER, R., Vaccine, 1994, 12, (4), 299–306.
  • Induction of cytolytic and antibody responses using Plasmodium falciparum repeatless circumsporozoite protein encapsulated in liposomes. WHITE, K., KRZYCH, U., GORDON, D. M., PORTER, T. G., RICHARDS, R. L., ALVING, C. R., DEAL, C. D., HOLLINGDALE, M., SILVERMAN, C., et al. Vaccine, 1993, 11, (13), 1341–1346.
  • Application of biodegradable systems for peptides and proteins: sustained-release lactide-glycolide microspheres. ERDEN, N., and CELEBI, N., FABAD Farm Bilimler. Derg., 1993, 18, (4), 161–171.
  • Microencapsulation processes for the manufacture of systems providing modified release of the active constituent. PORTE, H., and COUARRAZE, G., Handb. Powder Technol., 1994, 9, 513–543.
  • DDS using long-circulating liposomes. UNEZAK I, S., and MARUYAMA, K., y. jpn. Soc. Hosp. Pharm., 1994, 30, (3), 261–268.
  • Development of UV absorbent hollow organic microspheres. KIKUCHI, H., TAKAGI, M., KONDO, M., HONDA, K., TSUGITA, A., TOKUNAGA, K., and YONEYA, T., J. sccy, 1993, 27, (3), 441–449.
  • An XPS study on the interaction of the Fe304/Si02 boundary on the surface of composite microspheres prepared via the shear-compressive mechanical route. SAITO, I., and SENNA, M., Funtai Kogaku Kaishi, 1994, 31, (1), 18–24.
  • Extraction of hexavalent chromium ions with polyurea microcapsules. Ni, P., ZHANG, M., and YAN, N., .7. Membr. Sc., 1994, 89, (1–2), 1–8.
  • Synthesis of poly(styrene-methyl methacrylate) functional microspheres. ZHANG, X., and WANG, S., Gongneng Gaofenzi Xuebao, 1992, 5, (3), 208–213.
  • Novel, ordered, microphase-separated structure of the blends of a core-shell-type polymer microsphere and AB diblock copolymers with a lamellar morphology. SAITO, R., KOTSUBO, H., and IsHizu, K., Polymer, 1994, 35, (8), 1580–1585.
  • Ordered superstructure formation of core-shell-type microspheres. SAITO, R., KOTSUBO, H., and Isilizu, K., Polymer, 1994, 35, (8), 1747–1753.
  • Polypeptide liposome by spontaneous condensation in bilayer membranes. NISHIKAWA, N., ARAI, M., ONO, M., and IT0H, I., Chem. Lett., 1993, (12), 2017–2020.
  • Growth of recombinant fibroblasts in alginate microcapsules. CHANG, P. L., HORTELANO, G., TSE, M., and AWREY, D. E., Biotechnol. Bioeng., 1994, 43, (10), 925–933.
  • Liposomal transfection of human gamma-interferon gene into human glioma cells and adoptive immunotherapy using lymphokine-activated killer cells. MIZUNO, M., YOSHIDA, J., TAKAOKA, 1'., and SuoITA, K., J. Neurosurg., 1994, 80, (3), 510–514.
  • Protection of human respiratory epithelium from Pseudomonas aeruginosa adherence by phosphatidylglycerol liposomes. GIROD DE BENTZMANN, S., BAJ0LET, L. O., DUPUIT, F., PIERROT, D., FucHEY, C., PLOTKOWSKI, M C., and PUCHELLE, E., Infect. Immun., 1994, 62, (2), 704–708.
  • Microencapsulation of bovine spermatozoa for use in artificial insemination: a review. NEBEL, R. L., VISHWANATH, R., MCMILLAN, W. H., and SAACKE, R. G., Reprod., Fertil. Dev., 1993, 5, (6), 701–712.
  • Neoglycoprotein-liposome conjugates for studies of membrane lectins. YAMAZAKI, N., GABIUS, S., KOJIMA, S., and GABIUS, H. J., Lectins Glycobiol., Springer, Berlin, 1993, 319–326.
  • Quenching of merocyanine 540 triplet state by nitroxyl radicals in liposomal systems: a laser flash photolysis study. HOEBEKE, M., ENESCU, M., and LINDOVIST, L.,y. Photochem. Photobiol., B, 1994, 22, (3), 229–233.
  • Preparation and characterization of affinity-ligand-modified liposomes for trypsin separation. SUN, Y., Xu, X., and WANG, S., Huagong Xuebao (Chin. ed.), 1993, 44, (3), 359–365.
  • Activation of phospholipase A2 in 1-palmitoy1-2-oleoyl-sn-glycero-3-phosphocholine lipo-somes containing lipid ozonation products. SALc;o, M. G., SQUADRITO, G. L., and PRYOR, W. A., Chem. Res. Toxicol., 1994, 7, (3), 458–462.
  • Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes. PHILIP, R., BRUNETTE, E., KILINSKI, L., MURUGESH, D., MCNALLY, M. A., 1.:cAR, K., ROSENBLATT, J., OKARMA, T. B., and LEBKOWSKI, J. S., Mol. Cell Biol., 1994, 14, (4), 2411–2418.
  • Improvement of impaired brain monoamine metabolism by the cognition-enhancing agent nefiracetam after microsphere-induced cerebral embolism in rats. WATABE, S., TANIGUCHI, K., and KOJIMA, H., Arzneimittelforschung, 1994, 44, (2A), 195–198.
  • Cell death and DNA fragmentation induced by liposomal platinum(II) complex, L-NDDP in A2780 and A2780/PDD cells. HAN, I., LING, Y. H., KHOKHAR, A. R., and PEREZ, S. R., Anticancer-Res., 1994, 14, (2A), 421–426.
  • The ultrastructural characteristics of liposome interaction with bacterial cells. PEREVERZEV, N. A., SALOV, V. F., GRIGORIAN, G., and POPOV, V. L., Zh. Mihrobiol. Epidemiol. Immunobiol., 1994, (2), 3–7.
  • Retinal toxicity of the antimetabolite 5-fluorouridine 5'-monophosphate administered intravitreally using multivesicular liposomes. GAR1ANO, R. F., ARRIL, K. K., WILEY, C. A., MUNGUIA, D., WEINREB, R. N., and FREEMAN, W., Retina, 1994, 14, (1), 75–80.
  • Photodynamic therapy of B16 pigmented melanoma with liposome-delivered Si(IV)-naphthalocyanine. 13101.0, R., JORI, G., SONCIN, M., PRATESI, R., VANNI, U., RIHTER, B., KENNEY, M. E., and RODGERS, M. A., Photochem. Photobiol. 1994, 59, (3), 362–365.
  • Nasal application of the cationic liposome DC-Chol : DOPE does not alter ion transport, lung function or bacterial growth. MIDDI.ETON, P. G., CAPLEN, N. J., GA0, X., HUANG, L., GAYA, H., GEDDES, D. M., and ALTON, E. W., Eur. Respir. 1., 1994, 7, (3), 442–445.
  • Differential scanning calorimetry study on the binding of nucleic acids to dimyristoyl-phosphatidylcholine-sphingosine liposomes. Koiv, A., MUSTONEN, P., and KINNUNEN, P. K., Chem. Phys. Lipids, 1994, 70, (1), 1–10.
  • Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. YUAN, F., LEUNIG, M., HUANG, S. K., BEER, D. A., PAPAHADJOPOULOS, D., and JAIN, R. K., Cancer Res., 1994, 54, (13), 3352–3356.
  • Interferon-beta endogenously produced by intratumoral injection of cationic liposome-encapsulated gene: cytocidal effect on glioma transplanted into nude mouse brain.
  • YAGI, K., HAYASHI, Y., ISHIDA, N., OHBAYASHI, M., OHISHI, N., MIZUNO, M., and YOSHIDA, J., Biochem. Mol. Biol. Int., 1994, 32, (1), 167–171.
  • Improvements in the preparation of liposomes for electron microscopy and electronspectro-scopic imaging (ES). WE, S. J., and SMITH, N. B., Microsc. Res. Tech., 1994, 27, (6), 557–558.
  • The binding of human serum transferrin to its specific receptor reconstituted into liposomes. DI-Giumo, A., D'ANDREA, G., SALETTI, M. A., IMPAGNATIELLO, A., D'ALESSANDRO, A. M. and ORATORE, A., Cell Signal., 1994, 6, (1), 83–90.
  • Pharmacokinetics of harringtonine liposomes in rabbits. Wu, H. L., WENG, G. Y., Wu, Z. H., and Lu, Y. C., Chung Kuo Yao Li Hsueh Pao, 1994, 15, (1), 84–86.
  • Fate of methotrexate albumin microspheres after hepatic intra-arterial injection in dogs. Xu, F., and ZHU, Y. K., Chung Kuo Yao Li Hsueh Pao, 1993, 14 (6), 553–555.
  • Studies on pharmacologic disposition of adriamycin in dog after hepatic arterial embolization with adriamycin carboxymethyl-dextran-microspheres. HE, S. M., SUN, Y. C., WE, S. L., Wu, C. B., WANG, P. U., WANG, S. D., and XIE, J. X., Yao Hsueh Hsueh Pao, 1993, 28, (11), 859–864.
  • Characteristics of CDDP-PLA microspheres in vitro and in vivo. Liu, Z. K., WE, S. L., LAN, C. Q., and Su, D. Y., Yao Hsueh Hsueh Pao, 1993, 28, (10), 792–797.
  • Polyhydroxamic microcapsules prepared from proteins: a novel type of chelating microcap-sules. HETTLER, D., ANDRY, M. C., and LEVY, M. c.,y. Microencapsul., 1994, 11, (2), 213–224.
  • Microencapsulation with carrageenan-locust bean gum mixture in a multiphase emulsification technique for sustained drug release. Suzum, S., and Lim, J. K., Microencapsul., 1994, 11, (2), 197–203.
  • Microencapsulation of Lactococcus lactis subsp. cremoris. LARISCH, B. C., PONCELET, D., CHAMPAGNE, C. P., and NEUFELD, R. J.,.7. Microencapsul., 1994, 11, (2), 189–195.
  • Characterization and tissue distribution of liposomes containing lactose mono-fatty acid derivatives. YAMAUCHI, H., KIKUCHI, H., SAWADA, M., TOMIKAWA, M., and HIROTA, S., Microencapsul., 1994, 11, (2), 179–188.
  • Preparation of polyamide microcapsules having narrow size distributions. MURAMATSU, N., SHIGA, K., and KONDO, T., y. Microencapsul., 1994, 11, (2), 171–178.
  • Effect of compression pressure on physical properties and dissolution characteristics of disintegrating tablets of propranolol microspheres. CHIAO, C. S., and PRICE, J. C., y. Microencapsul., 1944, 11, (2), 161–170.
  • Formulation, preparation and dissolution characteristics of propranolol hydrochloride microspheres. CHIA°, C. S., and PRICE, J. C., y. Microencapsul., 1994, 11, (2), 153–159.
  • Sustained-release dosage form of nitrofurantoin. Part 1. Preparation of microcapsules and in vitro release kinetics. ERTAN, G., SARIGULLU, I., KARASULU, Y., ERCCAKIR, K., and GUNERI, T., y. Microencapsul., 1994, 11, (2), 127–135.
  • Successful treatment of AIDS-related pulmonary Kaposi's sarcoma with liposomal daunorubicin. SCHURMANN, D., DORMANN, A., GRUNEWALD, T., and RUF, B., Eur. Respir. y., 1994, 7, (4), 824–825.
  • Liposomal palmitoyl-L-asparaginase: characterization and biological activity. JORGE, J. C., PEREZ, S. R., MORAIS, J. G., and CRUZ, M. E., Cancer Chemother. Pharmacol., 1994, 34, (3), 230–234.
  • Cytokines in liposomes: preliminary studies with IL-1, IL-2, IL-6, GM-CSF and interferon-gamma. ANDERSON, P. M., HANSON, D. C., HASZ, D. E., HALET, M. R., BLAZAR, B. R., and OCHOA, A. C,, Cytokine, 1994, 6, (1), 92–101.
  • Fourier-transform infrared spectroscopic studies of cross-linked human serum albumin microcapsules. 2. Influence of reaction time on spectra and correlation with microcap-sule morphology and size. LEVY, M. C., LEFEBVRE, S., ANDRY, M. C., RAHMOUNI, M., and MANFAIT, M., Pharm. Sci., 1944, 83, (3), 419–422.
  • Correlation between monoamino oxidase inhibitor activity of some thiazol-2-ylhydrazines and their interaction with dipalmitoylphosphatidylcholine liposomes. CASTELLI, F., PIGNATELLO, R., SARPIETRO, M. G., MAZZONE, P., RACITI, G., and MAZZONE, G.,y. Pharm. Sc., 1994, 83, (3), 362–366.
  • A novel technique for the one-step preparation of liposomes and nonionic surfactant vesicles without the use of organic solvents. Liposome formation in a continuous gas stream: the 'bubble' method. TALSMA, H., VAN STEENBERGEN, M. J., BORCHERT, J. C., and CROMMELIN, D. J., y. Pharm. Sc., 1994, 83, (3), 276–280.
  • Microwave-induced lipid peroxidation in liposomes. BABINuovA, M., Folio Biol. (Praha), 1993,39, (5), 250–255.
  • Suppression of adjuvant-induced arthritis by liposomally conjugated methotrexate in the rat. WILLIAMS, A. S., CAMILLERI, J. P., and WILLIAMS, B. D., Br. J. Rheumatol., 1994, 33, (6), 530–533.
  • Radiation-induced cutaneo-muscular fibrosis (III): major therapeutic efficacy of liposomal Cu/Zn superoxide dismutase. LEFAIX, J. L., DELANIAN, S., LEPLAT, J. J., TRICAUD, Y., MARTIN, M., HOFFSCH IR, D., DABURON, F., and BAILLET, F., Bull. Cancer (Paris), 1993, 80,(9), 799–807.
  • Permeability and stability in buffer and in human serum of fluorinated phospholipid-based liposomes. FREZARD, F., SANTAELLA, C., VIERLING, P., and RIESS, J. G., Biochim. Biophys. Acta, 1994, 1192, (1), 61–70.
  • Liposome-induced activation of the classical complement pathway does not require immunoglobulin. MARIAN, J., XIE, Z., and DEVINE, D. V., Biochim. Biophys. Acta, 1994, 1192, (1), 35–44.
  • Activity of phospholipase A2 on a fluorescent substrate incorporated into non-hydrolyzable phospholipid liposomes. FERNANDEZ, M. S., and JUAREZ, J. A., Biochim. Biophys. Acta, 1994, 1192, (1), 132–142.
  • Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice. AGARAWAI„ A., KANDPA I., H., GUPTA, H. P., SINGH, N. B., and GUPTA, C. M., Antimicrob. Agents. Chemother., 1994, 38, (3), 588–593.
  • Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellular complex in human macrophages. ONYEJI, C. O., NIGHTINGALE, C. H., NICOLAU, D. P., and QUINTILIANI, R., Antimicrob. Agents. Chemother., 1994, 38, (3), 523–527.
  • The applicability of color-labeled microspheres in a rabbit model of ischemia-reperfusion. HASDAI, D., FUCHS, L., OHAD, D., and BATTLER, A., Angiology, 1994, 45, (6), 461–467.
  • Effects of intra-atrial injection of colored microspheres on systemic hemodynamics and regional blood flow in rats. KOBAYASHI, N., KOBAYASHI, K., KOUNO, K., HORINAKA, S., and YAGI, S., Am. y. Physiol., 1994, 266, (5 Pt 2), H1910–1917.
  • Glutaraldehyde cross-linked bovine casein microspheres as a matrix for the controlled release of theophylline: in-vitro studies. LATHA, M. S., and JAYAKRISHNAN, A., J. Pharm. Pharmacol., 1994, 46, (1), 8–13.
  • Incorporation of alpha-tocopherol in liposomes promotes the retention of liposome-encapsu-lated glutathione in the rat lung. SUNTRES, Z. E., and SHEK, P. N., y. Pharm. Pharmacol., 1994, 46, (1), 23–28.
  • Interaction of tocopherol with peroxyl radicals does not lead to the formation of lipid hydroperoxides in liposomes. DMITRIEV, L. F., IVANOVA, M. V., and LANKIN, V. Z., Chem. Phys. Lipids, 1994, 69, (1), 35–39.
  • A problem of quantitative measurement of regional cerebral blood flow using microsphere model and N-isopropyl-p-(123-I)iodoamphetamine (IMP): comparison with 133-Xe SPECT and sequential dynamic 123I-IMP SPECT. TAKAHASHI, N., OHKUBO, M., ODANO, I., OHTAKI, H., NOGUCHI, E., YAMAZAKI, Y., HATANO, M., and SARA, K., Kaku Igaku., 1994, 31, (4), 319–326.
  • Ocular absorption of cyclosporine A from liposomes incorporated into collagen shields. PLEYER, U., ELKINS, B., RUCKERT, D., LUTZ, S., GRAMMER, J., CHOU, J., SCHMIDT, K. H., and MONDINO, B. J., Curr. Eye Res., 1994, 13, (3), 177–181.
  • Feasibility of drug targeting to the retinal pigment epithelium with biodegradable micro-spheres. MORITERA, T., OGURA, Y., YOSHIMURA, N., KURIYAMA, S., HONDA, Y., TABA'FA, Y., and IKADA, Y., Curr. Eye Res., 1994, 13, (3), 171–176.
  • Canine bone blood flow measurements using serial microsphere injections. MCGRORY, B. J., MORAN, C. G., BRONK, J., WEAVER, A. L., and Woon, M. B., Clin. Orthop., 1994, (303), 264–279.
  • Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing mice. BALLY, NI. B., MASIN, D., NAYAR, R., Cu 1.1.1s, P. R., and MAYER, L. D., Cancer Chemother. Pharmacol., 1994, 34, (2), 137–146.
  • Cellular pharmacology of the partially non-cross-resistant anthracycline annamycin entrapped in liposomes in KB and KB-V1 cells. PEREZ, S. R., LING, Y. H., Z0u. Y., and PRIEBE, W., Cancer Chemother. Pharmacol., 1994, 34, (2), 109–118.
  • Effects of microsomes and liposomes on glutathione transferase catalysed conjugation of benzo(a)pyrene diol epoxide with glutathione. Oot, S. G., JERNSTROM, B., and AHOKAS, I., Chem. Biol. Interact., 1994, 91, (1), 15–27.
  • Analysis of the antimetastatic effects of synthetic muramyl tripeptide (CGP 19835A) encapsulated in liposomes in combination with other immunomodulatory agents and chemotherapeutic drugs. BEZAULT, J., WALSH, C., TARCSAY, L., FROST, H., LIEBES, L., and FURMANSKI, P., In Vivo, 1993, 7, (6A), 487–491.
  • The effect of cholesterol and dicetylphosphate on the physical parameters of liposomes. BONDAR, O. P., VOZHAN, P. A., DANCHUK, S. D., KURLIAND, D. 1., and KHOLODOVA, I. D., Biofizika, 1994, 39, (2), 323–327.
  • Calcium ions reverse a latency period induced by bovine serum albumin in the time course of phospholipase A2 action on 1,2-dipalmitoyl-sn-glycero-3-phosphocholine liposomes. PACHECO, F., MEJIA, R., and FERNANDEZ, M. S., Biochem. Cell. Biol., 1993, 71, (9-10), 462–466.
  • Aerosolized amphotericin B-liposomes for treatment of systemic Candida infections in mice. GILBERT, B. E., WYDE, P. R., LOPEZ, B. G., and WILSON, S. Z., Antimicrob. Agents Chemother., 1994, 38, (2), 356–359.
  • Radiation pneumonitis caused by yttrium-90 microspheres: radiologic findings. LIN. M., AYR Am. y. Roentgenol., 1994, 162, (6), 1300–1302.
  • Contraindications in the administration of 99Tcm-labelled macroaggregates or microspheres of albumin-any basis? (letter). BOLSTER, A. A. MURRAY, T., and Hi LD1TCH, T. E., Nucl. Med. Commun., 1994, 15, (3), 188–191.
  • Antitumor effect of interleukin-2 entrapped in liposomes on murine renal cell carcinoma. OYA, M., Keio. J. Med., 1994, 43, (1), 37–44.
  • Cell surface distribution of high-avidity LFA-1 detected by soluble ICAM-1-coated micro-spheres. PYSZNIAK, A. M., WELDER, C. A., and TAKEI, F., J. Immunol., 1994, 152, (11), 5241–5249.
  • Velocimetric and biochemical fetal effects of placental embolisation using microspheres in ewes. GAUCHERAND, P., PARISOT, P., FRANCK, M., TRAN, MINII, V., and RUDIGOZ, R. C., Eur. J. Obstet. Gynecol. Reprod. Biol., 1994, 53, (1), 49–53.
  • Tamoxifen decreases drug efflux from liposomes: relevance to its ability to reverse multidrug resistance in cancer cells? KAYYALI, R., MARRIOTT, C., and WISEMAN, H., FEBS Lett., 1994, 344, (2-3), 221–224.
  • Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors. BOMAN, N. L., MASIN. D., MAYER, L. D., CuLLIs, P. R., and BALLY, M. B., Cancer Res., 1994, 54, (11), 2830–2833.
  • Protein kinase C inhibitors suppress LPS-induced TNF production in alveolar macrophages and in whole blood: the role of encapsulation into liposomes. TSCHAIKOWSKY, K., Biochim. Biophys. Acta, 1994, 1222, (1), 113–121.
  • Xenotransplantation of microencapsulated canine islets into diabetic rats. CHEN, C. F., CHF:RN, H. T., LEL', F. J., CHANG, T. M., SHIAN, L. R., and SUN, A. M., Artif. Organs, 1994, 18, (3), 193–197.
  • Effect of microencapsulation on oxygen distribution in islets organs. SCHREZENMEIR, J., KIRCHGESSNER, J., GERO, L., KUNZ, L. A., BEYER, J., and MUELLER-KLIESER, W., Transplan-tation, 1994, 57, (9), 1308–1413.
  • Thrombin-induced platelet aggregation in the presence of negatively charged liposomes. ZAKREVSKII, V. I., and KIJBATIEV, A. A., Patol. Fiziol. Eksp. Ter., 1994, (I), 19–20.
  • Synthesis of polymeric microcapsule arrays and their use for enzyme immobilization. PARTHASARATHY, R. V., and MARTIN, C. R., Nature, 1994, 369, (6478), 298–301.
  • Biodegradable microspheres containing a colchicine analogue inhibit DNA synthesis in vascular smooth muscle cells. MARCH, K. L., MOHANRAJ, S., Ho, P. P., WILENSKY, R. L.,. and HATHAWAY, D. R., Circulation, 1994, 89, (5), 1929–1933.
  • Islet microencapsulation: a review. CLAYTON, H. A., JAMES, R. F., and LONDON, N. J., Acta Diabetol., 1993, 30, (4), 181–189.
  • Effect of pH of the medium on the liposome fusion process after treatment with alpha-latro-toxin. TERLETSKAIA, I. T., and TRIKASH, I. O., Biokhimiia, 1994, 59, (3), 441–448.
  • In vivo fluorescence and photodynamic activity of zinc phthalocyanine administered in liposomes. VAN LEENGOED, H. L., Cuomo, V., VERSTEEG, A. A., VAN DER VEEN, N., JoRi, G., and STAR, W. M., Br. y. Cancer, 1994, 69, (5), 840–845.
  • CGP 55398, a liposomal Ge(IV) phthalocyanine bearing two axially ligated cholesterol moieties: a new potential agent for photodynamic therapy of tumours. SEGALLA, A., MILANESI, C., .JORI, G., CAPRARO, H. G., IsELE, U., and SCHIEWECK, K., Br. y. Cancer, 1994, 69, (5), 817–825.
  • Direct plasmid mediated transfection of adult murine brain cells in vivo using cationic liposomes. RoEssi.ER, B. J., and DAVIDSON, B. L., Neurosci. Lett., 1994, 167, (1-2), 5–10.
  • A study on evaluation of CBF measurement based on microsphere model with N-isopropyl-p-(123-I)iodoamphetamine (IMP) and SPECT-its correction with the value of PaCO2. ODAN(.), I., TAKAHASHI, N., OFIKUBO, M., OHTAKI, H., NoGucHl, E., HATANO, Y., YAMAZAKI, Y., and NISHIHARA, M., Kaku Igaku, 1994, 31, (3), 223–229.
  • Fluorescent microspheres. (letter) ABEL., F. L., BECK., R. R., and COOPER, R. H., Y. Appl. Physiol., 1994, 76, (2), 986.
  • Liposome-entrapped PGE1 posttreatment decreases IL-1 alpha-induced neutrophil accumula-tion and lung leak in rats. LEFF, J. A., BAER, J. W., KIRKMAN, J. M., BODMAN, M. E., SHANLEY, P. F., CHO, O. J., Osmo, M. J., and REPINE, J. F.,]. Appl. Physiol., 1994, 76, (1), 151–157.
  • Liposomal N,N,N-trimethylsphingosine (TMS) as an inhibitor of 816 melanoma cell growth and metastasis with reduced toxicity and enhanced drug efficacy compared to free TMS: cell membrane signaling as a target in cancer therapy III. PARK, Y. S., HAKOMORI, S., KAWA, S., RUAN, F., and IGARASHI, Y., Cancer Res., 1994, 54, (8), 2213–2217.
  • Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. HUANG, S. K., STAt'FFER, P. R., HONG, K., Guo, J. W., PHILLIPS, T. L., HUANG, A., and PAPAHADJOPOULOS, D., Cancer Res., 1994, 54, (8), 2186–2191.
  • Induction of immunity against experimental tuberculosis with mycobacterial mannophos-phoinositides encapsulated in liposomes containing lipid A. SINGH, A. P., and KHULLER, G. K., FEMS Immunol. Med. Microbial., 1994, 8, (2), 119–126.
  • Potential usage of thermosensitive liposomes for macromolecule delivery. OKu, N., NARUSE, R., Doi, K., and OKADA, S., Biochim. Biophys. Acta, 1994, 1191, (2), 389–391.
  • Biodistributions of air-filled albumin microspheres in rats and pigs. WALDAY, P., TOLLESHAUG, H., GWEN, T., KINDBERG, G. M., BERG, T., SKOTLAND, T., and HOLTZ, E., Biochem. 1., 1994, 299, (Pt 2), 437–443.
  • Liposomes muramyl dipeptide derivatives, and nontoxic lipid A derivatives as adjuvants for human malaria vaccines. Hui, G. S., Am. J. Trop. Med. Hyg., 1994, 50, (45 Suppl.), 41–51.
  • Successful rat-to-mouse xenotransplantation of Langerhans islets microencapsulated within a protamine-heparin membrane. TATARKIEWICZ, K., SITAREK, E., FIEDOR, P., SABAT, M., MORZYCKA, M. M., and ORLOWSKI, T., Transplant Proc., 1994, 26, (2), 807–808.
  • Indefinite graft survival of discordant islet xenografts in the NOD mouse with agarose microencapsulation and 15-deoxyspergualin. AOMATSU, Y., NAKAJIMA, Y., IWATA, H., TAKAGI, T., AMEMIYA, H., KANEHIRO, H., HISANAGA, M., FUKUOKA, T., YOSHIMURA, A., KIDO, K. et al. Transplant Proc., 1994, 26, (2), 805–806.
  • Intraperitoneal transplantation of microencapsulated canine islet allografts with short-term, low-dose cyclosporine for treatment of pancreatectomy-induced diabetes in dogs. WAHOFF, D. C., STEPHANIAN, E., GORES, P. F., SOON, S. P., HOWER, C., LLOVERAS, J. K., and SUTHERLAND, D. E., Transplant Proc., 1994, 26, (2), 804.
  • Development of a microcapsule applicable to islet xenotransplantation. TAKAGI, T., IWATA, H., KOBAYASHI, K., OKA, T., Tsuji, T., and ITU, F., Transplant Proc., 1994, 26, (2), 801.
  • Microencapsulated transplantation of allogeneic islets into specifically presensitized recipients. SIEBERS, U., ZEKORN, T., HORCHER, A., KLOCK, G., HOUBEN, R., FRANK, H., BRETZEL, R. G., ZIMMERMANN, U., and FEDERLIN, K., Transplant Proc., 1994, 26, (2), 787–788.
  • Transplantation of microencapsulated islets in rats: evidence for induction of fibrotic overgrowth by islet alloantigens released from microcapsules. HoRCHER, A., ZEKORN, T., SIEBERS, U., KLOCK, G., FRANK, H., HOUBEN, R., BRETZEL, R. G., ZIMMERMANN, U., and FEDERLIN, K., Transplant Proc., 1994, 26, (2), 784–786.
  • Possible relationship between fibrotic overgrowth of alginate-polylysine-alginate micro-encapsulated pancreatic islets and the microcapsule integrity. DE VOS, P., WOLTERS, G. H., and VAN SCHILFGAARDE, R., Transplant Proc., 1994, 26, (2), 782–783.
  • Controlled release of albumin from chitosan-alginate microcapsules. Poi,x, A., AMSDEN, B., DE YAO, K., PENG, T., and GOOSEN, M. F., j. Pharm. Sci., 1994, 83, (2), 178–185.
  • Coating of liposomes with transferrin: physicochemical study of the transferrin-lipid system. EGEA, M. A., GARCIA, M. L., ALSINA, M. A., and REIG, F., y. Pharm. Sci., 1994, 83,(2), 169–173.
  • Comparison of the activity of free and liposomal amphotericin B in vitro and in a model of systemic and localized murine candidiasis. PAHLS, S., and SCHAFFNER, A., y. Infect. Dis., 1994, 169, (5), 1057–1061.
  • Chemoprevention and therapy of mouse mammary carcinomas with doxorubicin encapsu-lated in sterically stabilized liposomes. VAAGE, J., DONOVAN, D., LOFTUS, T, ARRA, R., WORKING, P., and HUANG, A., Cancer, 1994, 73, (9), 2366–2371.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.